Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 20, 2007

Merck KGaA and Nano Terra Embark on Nanotechnology Alliance

  • Merck KGaA and Nano Terra will develop solutions to create new physical properties in specialty chemicals, currently manufactured and sold by Merck.

    These solutions will allow Merck’s materials to be used with greater precision and control and allow for new applications at reduced economic levels never before possible, according to the companies.

    The new properties will be made through nanoscale, molecular fabrication methods. Nano Terra says it pioneered these techniques along with its co-founder, George M. Whitesides of Harvard University.

    The development work will be done primarily at Nano Terra’s lab facilities in Cambridge. Local support for the alliance will be provided by EMD Chemicals, Merck’s North American affiliate.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »